Contrasting Applied DNA Sciences ( NASDAQ : APDN ) and UL Solutions ( NYSE : ULS )

Applied DNA Sciences (APDN) and UL Solutions (ULS) are both industrial products companies, but their performance varies across several factors. Institutional ownership in Applied DNA Sciences is 22.2%, with 1.0% insider ownership, indicating some confidence from large investors. However, UL Solutions has higher institutional and insider ownership, suggesting stronger belief in its long-term market outperformance. In terms of profitability, Applied DNA Sciences has negative net margins, return on equity, and return on assets, while UL Solutions data is not available (N/A). UL Solutions has higher gross revenue and earnings compared to Applied DNA Sciences, but without profitability data, a direct comparison is challenging. Valuation and earnings show UL Solutions with higher revenue and earnings, but again, Applied DNA Sciences data is not provided. The consensus price target for Applied DNA Sciences is $1.50, with a potential upside of 9.49%, while UL Solutions has a consensus price target of $43.90, indicating a potential downside of 10.11%. Analyst ratings for Applied DNA Sciences show a mix of hold, sell, and buy recommendations, with a rating score of 3.00. In contrast, UL Solutions has more positive ratings, with 4 holds, 8 buys, and 0 sells, resulting in a higher rating score of 2.67. In summary, UL Solutions outperforms Applied DNA Sciences in institutional and insider ownership, revenue, and earnings. However, Applied DNA Sciences has a higher consensus rating and potential upside. Without complete profitability data, a comprehensive comparison is limited. Overall, analysts seem to favor UL Solutions over Applied DNA Sciences.

Source: themarketsdaily.com
Published on 2024-09-14